Florian Rieder1, Ilche Nonevski2, Jie Ma3, Zhufeng Ouyang2, Gail West4, Cheryl Protheroe5, Giovanni DePetris6, Anja Schirbel4, James Lapinski7, John Goldblum7, Tracey Bonfield8, Rocio Lopez9, Karen Harnett3, James Lee5, Ikuo Hirano10, Gary Falk2, Piero Biancani3, Claudio Fiocchi11. 1. Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio; Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio. 2. Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio. 3. Rhode Island Hospital and Brown University, Providence, Rhode Island. 4. Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio. 5. Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona. 6. Department of Laboratory Medicine/Pathology, Mayo Clinic Arizona, Scottsdale, Arizona. 7. Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio. 8. Division of Pediatric Pulmonology, Case Western Reserve University, Cleveland, Ohio. 9. Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio. 10. Division of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 11. Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio; Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio. Electronic address: fiocchc@ccf.org.
Abstract
BACKGROUND & AIMS: Patients with eosinophilic esophagitis (EoE) often become dysphagic from the combination of organ fibrosis and motor abnormalities. We investigated mechanisms of dysphagia, assessing the response of human esophageal fibroblasts (HEFs), human esophageal muscle cells (HEMCs), and esophageal muscle strips to eosinophil-derived products. METHODS: Biopsy specimens were collected via endoscopy from the upper, middle, and lower thirds of the esophagus of 18 patients with EoE and 21 individuals undergoing endoscopy for other reasons (controls). Primary cultures of esophageal fibroblasts and muscle cells were derived from 12 freshly resected human esophagectomy specimens. Eosinophil distribution was investigated by histologic analyses of full-thickness esophageal tissue. Active secretion of EoE-related mediators was assessed from medium underlying mucosal biopsy cultures. We quantified production of fibronectin and collagen I by HEF and HEMC in response to eosinophil products. We also measured the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of human eosinophils to, HEFs and HEMCs. Eosinophil products were tested in an esophageal muscle contraction assay. RESULTS: Activated eosinophils were present in all esophageal layers. Significantly higher concentrations of eosinophil-related mediators were secreted spontaneously in mucosal biopsy specimens from patients with EoE than controls. Exposure of HEFs and HEMCs to increasing concentrations of eosinophil products or co-culture with eosinophils caused HEFs and HEMCs to increase secretion of fibronectin and collagen I; this was inhibited by blocking transforming growth factor β1 and p38 mitogen-activated protein kinase signaling. Eosinophil binding to HEFs and HEMCs increased after incubation of mesenchymal cells with eosinophil-derived products, and decreased after blockade of transforming growth factor β1 and p38 mitogen-activated protein kinase blockade. Eosinophil products reduced electrical field-induced contraction of esophageal muscle strips, but not acetylcholine-induced contraction. CONCLUSIONS: In an analysis of tissues samples from patients with EoE, we linked the presence and activation state of eosinophils in EoE with altered fibrogenesis and motility of esophageal fibroblasts and muscle cells. This process might contribute to the development of dysphagia.
BACKGROUND & AIMS:Patients with eosinophilic esophagitis (EoE) often become dysphagic from the combination of organ fibrosis and motor abnormalities. We investigated mechanisms of dysphagia, assessing the response of human esophageal fibroblasts (HEFs), human esophageal muscle cells (HEMCs), and esophageal muscle strips to eosinophil-derived products. METHODS: Biopsy specimens were collected via endoscopy from the upper, middle, and lower thirds of the esophagus of 18 patients with EoE and 21 individuals undergoing endoscopy for other reasons (controls). Primary cultures of esophageal fibroblasts and muscle cells were derived from 12 freshly resected human esophagectomy specimens. Eosinophil distribution was investigated by histologic analyses of full-thickness esophageal tissue. Active secretion of EoE-related mediators was assessed from medium underlying mucosal biopsy cultures. We quantified production of fibronectin and collagen I by HEF and HEMC in response to eosinophil products. We also measured the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of human eosinophils to, HEFs and HEMCs. Eosinophil products were tested in an esophageal muscle contraction assay. RESULTS: Activated eosinophils were present in all esophageal layers. Significantly higher concentrations of eosinophil-related mediators were secreted spontaneously in mucosal biopsy specimens from patients with EoE than controls. Exposure of HEFs and HEMCs to increasing concentrations of eosinophil products or co-culture with eosinophils caused HEFs and HEMCs to increase secretion of fibronectin and collagen I; this was inhibited by blocking transforming growth factor β1 and p38 mitogen-activated protein kinase signaling. Eosinophil binding to HEFs and HEMCs increased after incubation of mesenchymal cells with eosinophil-derived products, and decreased after blockade of transforming growth factor β1 and p38 mitogen-activated protein kinase blockade. Eosinophil products reduced electrical field-induced contraction of esophageal muscle strips, but not acetylcholine-induced contraction. CONCLUSIONS: In an analysis of tissues samples from patients with EoE, we linked the presence and activation state of eosinophils in EoE with altered fibrogenesis and motility of esophageal fibroblasts and muscle cells. This process might contribute to the development of dysphagia.
Authors: Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman Journal: J Allergy Clin Immunol Date: 2012-04-01 Impact factor: 10.793
Authors: Joohee Lee; James Huprich; Christine Kujath; Karthik Ravi; Felicity Enders; Thomas C Smyrk; David A Katzka; Nicholas J Talley; Jeffrey A Alexander Journal: Clin Gastroenterol Hepatol Date: 2012-02-03 Impact factor: 11.382
Authors: S Roman; I Hirano; M A Kwiatek; N Gonsalves; J Chen; P J Kahrilas; J E Pandolfino Journal: Neurogastroenterol Motil Date: 2010-11-23 Impact factor: 3.598
Authors: Jonathan M Spergel; Marc E Rothenberg; Margaret H Collins; Glenn T Furuta; Jonathan E Markowitz; George Fuchs; Molly A O'Gorman; Juan Pablo Abonia; James Young; Timothy Henkel; H Jeffrey Wilkins; Chris A Liacouras Journal: J Allergy Clin Immunol Date: 2011-12-28 Impact factor: 10.793
Authors: Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka Journal: Am J Gastroenterol Date: 2013-04-09 Impact factor: 10.864
Authors: Amanda B Muir; Kara Dods; Steven J Henry; Alain J Benitez; Dale Lee; Kelly A Whelan; Maureen DeMarshall; Daniel A Hammer; Gary Falk; Rebecca G Wells; Jonathan Spergel; Hiroshi Nakagawa; Mei-Lun Wang Journal: J Pediatr Gastroenterol Nutr Date: 2016-08 Impact factor: 2.839
Authors: Evan S Dellon; Jessica H Gebhart; Leana L Higgins; Kelly E Hathorn; John T Woosley; Nicholas J Shaheen Journal: Gastrointest Endosc Date: 2015-07-02 Impact factor: 9.427